Vertex to Report Fourth Quarter and Full Year 2012 Financial Results on Tuesday, January 29

  Vertex to Report Fourth Quarter and Full Year 2012 Financial Results on
  Tuesday, January 29

Business Wire

CAMBRIDGE, Mass. -- January 15, 2013

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth
quarter and full year 2012 financial results on Tuesday, January 29, 2013
after the financial markets close. The company will host a conference call at
5:00 p.m. ET.

The conference call will be webcast live and a link to the webcast may be
accessed from the “Vertex Events” page of Vertex’s website at www.vrtx.com. A
replay of the conference call and webcast will be archived on the company’s
website until February 5, 2013. To ensure a timely connection, it is
recommended that users register at least 15 minutes prior to the scheduled
webcast.

About Vertex

Vertex creates new possibilities in medicine. Our team discovers, develops and
commercializes innovative therapies so people with serious diseases can lead
better lives.

Vertex scientists and our collaborators are working on new medicines to cure
or significantly advance the treatment of hepatitis C, cystic fibrosis,
rheumatoid arthritis and other life-threatening diseases.

Founded more than 20 years ago in Cambridge, Mass., we now have ongoing
worldwide research programs and sites in the U.S., U.K. and Canada. Today,
Vertex has more than 2,000 employees around the world, and for three years in
a row, Science magazine has named Vertex one of its Top Employers in the life
sciences. Vertex’s press releases are available at www.vrtx.com.

VRTX-WEB

Contact:

Vertex Pharmaceuticals Incorporated
Kate Carlson, 617-341-6668
Investor Relations
 
Press spacebar to pause and continue. Press esc to stop.